PHATHOM PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": -61000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | PHATHOM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:03:08.420042+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6005a5c5-b462-4912-97dd-56f4be06b9e0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-193946Retrieved: 2026-08-19T18:03:08.420042+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001783183/cashflow-investing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6005a5c5-b462-4912-97dd-56f4be06b9e0
History
- no predecessors — first report